This book analyzes how the increasing number of same-sex couples is changing the traditional concepts of family and parenthood, and how these changes affect the psychological studies of family, couple relationships and human development. The majority of chapters included in this contributed volume present results of research conducted with LGBTQ+ people in Brazil, a country where same-sex couples have been recognized by the national legislation since 2011, but is currently facing a conservative wave which threatens much of the victories gained by the LGBTQ+ movement in recent years. That's why this book aims to provide both updated theoretical and methodological contributions as well as ethically and political engaged reflections to the field of psychological studies of LGBTQ+ parenting and couple relationships. Chapters in this volume analyze different aspects of LGBTQ+ parenting and couple relationships, such as changes in the concept of family; the role of the family of origin in the coming out process of young adults; risk and protective factors in couple relationships between lesbians and gay men; vulnerabilities experienced by trans couples during the COVID-19 pandemic; how lesbians, gays, trans and non-binaries are approaching parenting and raising their families; factors that shape the reproductive decisions of LGBTQ+ individuals; adoption and coparenting in families composed of gay and lesbian couples, among other topics. Parenting and Couple Relationships Among LGBTQ+ People in Diverse Contexts will be of interest to social, developmental and family psychologists and social workers researching and working with same-sex couples and families, and with the LGBTQ+ population in general.

This volume provides a comprehensive overview of recent advances in targeting glutamate signaling for the treatment of major psychiatric and neurological disorders. It draws on the latest findings in glutamate neurobiology and offers valuable insights into the application of translational principles in neuroscience drug discovery and development. In each chapter, glutamate as a neurotransmitter, its receptors and transporters, and their interplay with other neurotransmitters and neurotrophic factors, are discussed in the context of a specific, highly prevalent and disabling CNS disease. Most recent and detailed information is provided on Ischemic Stroke, Chronic Stress, Major Depressive Disorder, Bipolar Disorder, Autism Spectrum Disorders (ASD), Posttraumatic Stress Disorder (PTSD), Alzheimer's Dementia, Schizophrenia, Impulsive Aggression, Substance Use Disorders (SUD), Amyotrophic Lateral Sclerosis (ALS), Chronic Pain, Multiple Sclerosis, Parkinson's Disease, Attention Deficit Hyperactivity Disorder (ADHD), Migraine, Epilepsy and Anxiety disorders. Moreover, the book includes an extensive overview of glutamatergic treatments already available on the market, and those which are currently in pharmaceutical drug development pipelines. The primary beneficiaries will be neurology and psychiatry specialists and residents, neuroscientists, neuropharmacologists, pharmaceutical industry and clinical research organization professionals, academics, and clinicians working with psychiatric and neurological patients with comorbidities such as cardiologists, pulmonologists, and endocrinologists. This book will also appeal to psychiatry and neurology subspecialists and clinicians working in neuroscience labs seeking an easy-to-understand yet comprehensive overview of contemporary evidence-based clinical insights backed by basic science (preclinical) research evidence. Given its scope, the book is also a unique and indispensable resource for both preclinical and clinical neuroscientists, medical advisors, and clinical research specialists in the pharmaceutical industry. In addition, it will appeal to neuroscience and neuropsychopharmacology students and guide them through the complexities of glutamate involvement in the pathophysiology of the most common debilitating brain diseases with high unmet medical needs.

Betty Berzon, renowned psychotherapist and author of the bestselling book "Permanent Partners," tells her own incredible story here. Berzon's journey from psychiatric patient on suicide watch--her wrists tethered to the bed rails in a locked hospital ward--to her present role as a groundbreaking therapist and gay pioneer makes for purely compelling reading.
Berzon is recognized today as a trailblazing co-founder of a number of important lesbian and gay organizations and one of the first therapists to focus on means of developing healthy gay relationships and overcoming homophobia. Her sometimes bumpy road to success never fails to fascinate. Along the way she encounters such luminaries as Anais Nin, Eleanor Roosevelt, the Sitwells, Evelyn Hooker, and Paul Monette. Her recollections here provide a collective portrait of her fellow pioneers and a stirring lesson in twentieth-century history.
It is, however, the intimate story of Berzon's own private passage toward self-discovery--from mental breakdown and suicide attempts, through hospitalization, eventual triumphant recovery, and her own coming out as an open lesbian at the age of forty--that makes this memoir an urgent, insightful, and deeply emotional testament to human survival.

In this timely volume, leading behavioral scientists describe recent advances in our understanding of the multiple biopsychosocial regulatory processes underlying the development of children s behavior disorders. A full spectrum of regulatory influences is addressed, ranging from genes to cultural factors. Individual chapters highlight the importance of developing research paradigms that synthesize biological, behavioral, and social-ecological influences, and of viewing self-regulation as a complex system that reorganizes across development. The regulatory foundations of a diverse range of childhood behavior problems are examined, including anxiety, social withdrawal, depression, conduct problems, inattention and impulsivity, and sleep problems.

First published in 1992. Part I of the book covers phases of treatment for specific phases of recovery by describing key concepts and focusing on three dominant treatment modalities, inpatient, outpatient, and long-term residential therapeutic communities. Part II covers, in substantial depth, psychoanalytic/psychodynamic approaches. art III of the book examines cognitive-behavioral, self-help, and relapse prevention approaches to the treatment of the chemically dependent. Part VI mentions in all phases of treatment and recovery. Part IV of the book provides an overview of contemporary trends in research, while also discussing implications for treatment. n the therapeutic community. Part V attempts to draw the field of chemical dependency toward recognition of the importance of considering distinct population characteristics and how these characteristics may dictate modifications in treatment design. The book is suitable as a text in a course on substance abuse or as a critical reference for anyone doing clinical work or research in the field of chemical dependency.

When it was first published in 1980, the Diagnostic and Statistical Manual of Mental Disorders, Third Edition--univer-sally known as DSM-III--embodied a radical new method for identifying psychiatric illness. Kirk and Kutchins challenge the general understanding about the research data and the pro-cess that led to the peer acceptance of DSM-III. Their original and controversial reconstruction of that moment concen-trates on how a small group of researchers interpreted their findings about a specific problem--psychiatric reliability--to promote their beliefs about mental illness and to challenge the then-dominant Freudian paradigm.

Adolescent Stress concentrates on a range of major problems-those of a normal developmental nature as well as those of poor adaptation-identified in adolescents.

Somewhere between 11% and 22% of adolescents seeking mental health care in outpatient clinics-and between 33% and 49% of those in inpatient units-meet the diagnostic criteria for borderline personality disorder (BPD). Despite its high prevalence, however, and the high social and economic costs that it entails, BPD remains underdiagnosed, and sufficient training regarding its fundamentals and clinical management is largely unavailable for mental health professionals treating adolescents. It is precisely these essential guidelines that clinicians will find in the Handbook of Good Psychiatric Management for Adolescents With Borderline Personality Disorder. Adapted from Dr. John Gunderson's good psychiatric management (GPM), a resource-efficient generalist treatment for adults with BPD, this manual uses GPM for adolescents (GPM-A) to demystify BPD in young people, describing common problems that arise during each phase or aspect of treatment, from patient rejection of diagnosis and conflicts among clinicians providing care to nonadherence to medications and concerns about stigma. Case vignettes that feature key decision points propose alternative interventions and demonstrate how to apply the book's concepts in a variety of settings. Additionally, speech bubbles throughout the handbook offer suggestions for how to phrase explanations and interventions to communicate effectively with adolescent patients at an appropriate level. Although the pragmatic GPM-A principles outlined in this book are based on real-world experience and bolstered by scientific evidence, they are not intended to be an end point for treatment. They are, rather, a road map to provide "good enough" care even in the absence of specialized treatments, and clinicians are encouraged to adjust the lessons as needed for their practice. The education provided in the handbook is meant to be shared with patients, their families, schools, clinical teams, and trainees as a resource for motivation in persevering with the difficult but worthwhile investments in treatment.

This volume reflects the achievements in developing new concepts and models of family therapy and new approaches to special clinical issues and problems during the 1980s. Chapters by experts such as Boszormenyi-Nagy, Everett, Guttman, Lankton, Liddle, McGoldrick, Madanes, and Walsh offer insight into a variety of areas including systems theory, cybernetics, and epistemology; contextual therapy; Ericksonian therapy; strategic family therapy; treating divorce in family therapy practice; ethnicity and family therapy; and training and supervision in family therapy.

Related link: Free Email Alerting

Handbook of Effective Psydwtherapy is the culmination of 15 years of personal interest in the area of psychotherapy outcome research. In my view, this is one of the most interesting and crucial areas in the field: it has relevance across disparate clinical disciplines and orientations; it provides a measure of how far the field has progressed in its efforts to improve the effectiveness of psychotherapeutic inter vention; and it provides an ongoing measure of how readily clinicians adapt to scientific indications in state-of-the-art care. Regrettably, as several of the chapters in this volume indicate, there is a vast chasm between what is known about the best available treatments and what is applied as the usual standard of care. On the most basic level there appears to be a significant number of clinicians who remain reluctant to acknowledge that scien tific study can add to their ability to aid the emotionally distressed. I hope that this handbook, with its many delineations of empirically supported treatments, will do something to remedy this state of affairs."

Related link: Free Email Alerting
eBook available with sample pages: 0203405978

This book addresses the over-prescribing of antidepressants in people with mostly mild and subthreshold depression. It outlines the steep increase in antidepressant prescription and critically examines the current scientific evidence on the efficacy and safety of antidepressants in depression. The book is not only concerned with the conflicting views as to whether antidepressants are useful or ineffective in various forms of depression, but also aims at detailing how flaws in the conduct and reporting of antidepressant trials have led to an overestimation of benefits and underestimation of harms. The transformation of the diagnostic concept of depression from a rare but serious disorder to an over-inclusive, highly prevalent but predominantly mild and self-limiting disorder is central to the books argument. It maintains that biological reductionism in psychiatry and pharmaceutical marketing reframed depression as a brain disorder, corroborating the overemphasis on drug treatment in both research and practice. Finally, the author goes on to explore how pharmaceutical companies have distorted the scientific literature on the efficacy and safety of antidepressants and how patient advocacy groups, leading academics, and medical organisations with pervasive financial ties to the industry helped to promote systematically biased benefit-harm evaluations, affecting public attitudes towards antidepressants as well as medical education, training, and practice.

Here is a thoughtful new book for professionals who assist persons afflicted with neuromuscular disorders to help them and their families adapt to lifestyle changes accompanying the onset of these disorders. Health care professionals provide strategies to maintain the psychosocial well-being of children and adults with neuromuscular disorders which, in addition to physical damage, also assault the sense of self and challenge the individual's ability to move and communicate. Chapters describe the psychosocial aspects of a variety of neuromuscular diseases such as Duchenne and myotonic muscular dystrophy, multiple sclerosis, amyotrophic lateral sclerosis, Friedeich's ataxia, and Charcot-Marie-Tooth disease. The distinctive characteristics of each disease are examined with special attention given to the natural history, treatment, management, and psychosocial issues of the specific disorder. Beyond the clinical and research importance of Muscular Dystrophy and Other Neuromuscular Diseases, it also addresses the anxiety, doubts, and questions felt by patients with chronic progressive disabilities and their families. This helpful guide is unique in the way it features the interaction of professionals in the social services, psychology, religion, and various medical specialties in the care and treatment of these patients. Professionals in all of these disciplines, as well as the patients and families afflicted by these disorders, will benefit from this valuable resource.

Highlighting the current developments and future directions in GABA and glycine research, this volume covers the major inhibitory neurotransmitters from the molecular mechanisms of signal transduction to their role in health and disease. It is of topical importance because these neurotransmitters are essential for brain function and therapy of diseases such as anxiety disorders, insomnias, epilepsy, depression, spasticity, and memory deficits. Distinguished scientists at the forefront of research contributed reviews on the role of these transmitters in governing neuronal networks, their signalling pathways, their receptors, the pharmacology of GABA A- and GABA B- and GABA C-receptors as well as of GABA- and glycine-transporters, and their role in disease. The volume serves as reference for pharmacologists/toxicologists, neuroscientists, neurologists and psychiatrists.

Starting with the Foreword by Daniel Siegel, MD, the "Handbook" demonstrates in superb detail how you can combine EMDR's information processing approach with family systems perspectives and therapy techniques. An impressive and needed piece of work, "Handbook of EMDR and Family Therapy Processes" provides a clear and comprehensive bridge between individual and family therapies.

After 30 years of declining practice among psychiatrists, psychotherapy is being increasingly recognized as a valuable tool in psychiatric care. While this renewed appreciation offers hope for the future, a serious challenge remains: There are alarmingly few psychiatrists equipped as psychotherapy supervisors to help train the next generation of psychiatrists. Encouraging psychiatrists to consider stepping into this important role is what makes Supervising Individual Psychotherapy such a timely and indispensable resource. With a multipronged approach that combines the theoretical and the practical, supported by illustrative clinical vignettes, this guide focuses on four key areas: • The process of supervisor development, including helpful tools for building supervisory skills and fostering self-growth, practical methods for establishing and maintaining a healthy supervisory relationship, and a collection of vignettes to highlight the supervisee's perspective. Also addressed are common ethical questions that arise in the supervisory process. • Specific techniques used in supervision, including how to establish and monitor goals for supervision, provide supervision via internet-mediated videoconferencing, and thoughtfully plan for the termination of supervision. • Psychotherapy supervision for specific populations and within various care settings, including supervision of supportive therapy in hospital units and emergency departments, cognitive-behavioral therapy, substance use disorder treatment, and combination treatment of psychotherapy and pharmacotherapy. Also discussed are the possible effects of the supervisee's and the supervisor's race, gender identity, and sexual preferenceorientation on the supervisory process. • Challenges that may arise in supervision, including an examination of the effects of marriage, divorce, illness, and death on the supervisory dyad; the legal aspects of supervision (e.g., confidentiality, medicolegal liability); and the risks of burnout in both the supervisor and the supervisee. With a richness of detail organized in an accessible and easy-to-reference format, this book clearly covers the skills, capabilities, and qualities needed to provide effective psychotherapy supervision—and is tailor-made for early- and mid-career supervisors who are looking to develop and refine their skills.

Draws on 18 months of the author's fieldwork. Demonstrates how service users can work creatively with the clinical circuitries, biomedical imaginaries and temporal underpinnings of clozapine treatment to personalise their experiences and to exert subtle personal power over their health and future prospects. The first ethnography to examine clozapine treatment in the UK and Australia.

Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders, Second Edition provides basic scientists a comprehensive overview of neurological and neuropsychiatric disease. This book links basic, translational, and clinical research, covering the genetic, developmental, molecular and cellular mechanisms underlying all major categories of brain disorders. It offers students, postdoctoral fellows, and researchers in diverse fields of neuroscience, neurobiology, neurology, and psychiatry the tools they need to obtain a basic background in the major neurological and psychiatric diseases. Topics include developmental, autoimmune, central, and peripheral neurodegeneration, infectious diseases, and diseases of higher function. Organized by individual disorder, each chapter includes coverage of the clinical condition, diagnosis, treatment, underlying mechanisms, relevant basic and translational research, and key unanswered questions. This volume reflects progress in the field since publication of the first edition, with fully updated chapters, and new chapters on isolation, aging, global diseases, vascular diseases, and toxic/metabolic disease. New disorder coverage includes fibromyalgia, chronic fatigue, Restless Legs Syndrome, myasthenia gravis, and more.

The second edition of this successful handbook, edited by well-known experts in this field, includes core questions in the field of child abuse and neglect. It addresses major challenges in child maltreatment work, starting with "What is child abuse and neglect?" and then examines why maltreatment occurs and what are its consequences. The handbook also addresses prevention, intervention, investigation, treatment as well as civil and criminal legal perspectives. It comprehensively studies the issue from the perspective of a broader, international and cross-cultural human experience. Apart from a thorough revision of existing chapters, this edition includes many new chapters covering recent developments in this area and other issues not covered in the first edition. There is more focus on substance abuse, psychological abuse, and on social and community involvement and public health provisions in the prevention of child maltreatment. The handbook examines what is known now and more importantly what remains to be researched in the coming decades to help abused and neglected children, their families and their communities, thereby taking the field forward.

This volume uncovers the roots of electroshock in America, an outgrowth of western patriarchal medicine with primarily female patients. The history of electroshock in the United States in three historic stages is chronicled as it alternated from an enthusiastic reception in 1940, to a period of crisis in the 1960s, to its resurgence after 1980. Early American experiments with electrical medicine are also examined, while the development of electroshock in America is considered through the lens of social, political, and economic factors. The revival of electroshock in recent decades is found to be a product of growing materialism in American psychiatry and the political and economic realities of managed medical care.

Kneeland and Warren suggest that the choice of electroshock, made in an era when a number of other medical therapies were available, was connected to American enthusiasm for electricity and technology in the early 20th century. Temporary rejection of electroshock in the 1960s is explained as the outcome of both an internal crisis in psychiatric authority and the external political and social pressure on psychiatry created by the civil rights movement. Scholars and students considering the history of psychology, psychiatry, science, and medicine or the history of technology will find this volume helpful.

Increase your understanding of the link between alcoholism and shame and guilt with this tremendously important book that adds to our understanding of the total recovery process. This practical volume authoritatively defines the often elusive terms of shame and guilt and provides constructive suggestions to therapists for treating alcoholic clients and affected family members who are suffering from excessive quantities of shame and guilt. Shame, Guilt, and Alcoholism thoroughly explains to therapists the significant differences between shame and guilt as displayed by clients'experiences of failure, primary responses and feelings, precipitating events and involvement of self, and origins and central fears. Author Potter-Efron includes creative approaches to the general treatment of shame and guilt, explores the positive functions of shame and guilt, describes the conscious and subconscious defense mechanisms against shame and guilt, and highlights the very crucial family behaviors that initiate and encourage shame and guilt. Shame, Guilt, and Alcoholism adds immeasurably to our understanding of the total recovery process.

This work is the most comprehensive volume to focus on new directions in professional practice with families of people with mental illness. It offers a multidisciplinary systems-oriented examination of theory, research, and practice in the area. Unique features include a consideration of life-span and family system and subsystem perspectives, as well as the inclusion of powerful personal accounts of family members. It is written from the perspective of a competence paradigm for clinical practice, which offers a constructive alternative to the more prevalent pathology models of the past.

This work is the most comprehensive volume to focus on new directions in professional practice with families of people with mental illness. It offers a multidisciplinary systems-oriented examination of theory, research, and practice in the area. Unique features include a consideration of life-span and family system and subsystem perspectives, as well as the inclusion of powerful personal accounts of family members. It is written from the perspective of a competence paradigm for clinical practice, which offers a constructive alternative to the more prevalent pathology models of the past. In the era following deinstitutionalization, families often have served as an extension of the mental health system. There is much evidence that the needs of families are often poorly met. In response to the shortcomings of the system and to their own anguish, families have become increasingly assertive in articulating their needs for respect, support, information, skills, resources, and services. This volume is designed to provide professionals with increased understanding of the experiences and needs of families, as well as with concrete suggestions for enhancing their effectiveness in meeting those needs.

The first three chapters are designed to explore general issues related to the family experience and family-professional relationships, the conceptual and empirical context, and new directions in professional practice. The next six chapters provide the experiential core of the volume, covering such topics as life-span perspectives, the subjective and objective burden, the family system, family subsystems, coping and adaptation, and the needs of families. The final three chapters are concerned with intervention, including nonclinical strategies that are designed primarily to educate and support families, and clinical strategies that are designed primarily to provide treatment. The nonclinical and clinical intervention strategies that are discussed have the potential to comprise a full continuum of family-oriented services that can be tailored to the needs, desires, and resources of particular families. The final chapter is concerned with intervention on the level of the mental health system.

The study of drug effects on behavior is truly a confluence of streams of neuroscience research. The material in this volume covers a broad range of methodology representative of practically the entire scope of psychopharmacology for conscious animals. The contributions in this book represent careful evaluations by experts who were invited to participate because of their excellent practical application of research design and methodology. In each case, a particularly useful and well-written contribution has been forthcoming, and should serve either as a valuable introduction to developing researchers or as a practical reference to those active in the field. The material is arranged in an intuitive hierarchy. This arrangement is based on what are ostensibly increasing levels of integrated activity of the nervous system and, therefore, increasing levels of behavioral integration. Nevertheless, as all of the areas covered are rather detailed in their levels of intrinsic complexity, this arrangement of chapters does not imply successively more intricate problems. The reader will find some overlap between chapters, but little interdependence, i.e., each may be read as a separate or as an integral part of the volume.